Oxford Biodynamics PLC - Asset Resilience Ratio

Latest as of September 2024: 8.26%

Oxford Biodynamics PLC (OBD) has an Asset Resilience Ratio of 8.26% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Oxford Biodynamics PLC (OBD) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

GBX1.00 Million
≈ $121.67 USD Cash + Short-term Investments

Total Assets

GBX12.11 Million
≈ $1.47K USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Oxford Biodynamics PLC's Asset Resilience Ratio has changed over time. See OBD net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Oxford Biodynamics PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Oxford Biodynamics PLC.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents GBX0.00 0%
Short-term Investments GBX1.00 Million 8.26%
Total Liquid Assets GBX1.00 Million 8.26%

Asset Resilience Insights

  • Limited Liquidity: Oxford Biodynamics PLC maintains only 8.26% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Oxford Biodynamics PLC Industry Peers by Asset Resilience Ratio

Compare Oxford Biodynamics PLC's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Sonic Healthcare Ltd
AU:SHL
Diagnostics & Research 0.13%
Eurofins-Cerep SA
PA:ALECR
Diagnostics & Research 6.56%
Inoviq Ltd
AU:IIQ
Diagnostics & Research 56.29%
Bcal Diagnostics Ltd
AU:BDX
Diagnostics & Research 0.00%
Imagion Biosystems Ltd
AU:IBX
Diagnostics & Research 150.16%
Integral Diagnostics Ltd
AU:IDX
Diagnostics & Research 0.03%
Australian Clinical Labs Ltd
AU:ACL
Diagnostics & Research 4.11%
Monash Ivf Group Ltd
AU:MVF
Diagnostics & Research 1.60%

Annual Asset Resilience Ratio for Oxford Biodynamics PLC (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Oxford Biodynamics PLC.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-09-30 8.26% GBX1.00 Million
≈ $121.67
GBX12.11 Million
≈ $1.47K
+8.04pp
2022-09-30 0.22% GBX25.00K
≈ $3.04
GBX11.34 Million
≈ $1.38K
-13.84pp
2021-09-30 14.06% GBX2.16 Million
≈ $263.17
GBX15.38 Million
≈ $1.87K
-21.02pp
2020-09-30 35.09% GBX5.39 Million
≈ $655.44
GBX15.35 Million
≈ $1.87K
-19.72pp
2019-09-30 54.81% GBX10.30 Million
≈ $1.25K
GBX18.79 Million
≈ $2.29K
--
pp = percentage points

About Oxford Biodynamics PLC

LSE:OBD UK Diagnostics & Research
Market Cap
$107.03K
GBX879.64 Million GBX
Market Cap Rank
#30966 Global
#1104 in UK
Share Price
GBX0.21
Change (1 day)
+0.00%
52-Week Range
GBX0.19 - GBX0.60
All Time High
GBX274.50
About

Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor i… Read more